Cite

HARVARD Citation

    Colman, R. et al. (n.d.). REAL-WORLD VEDOLIZUMAB PHARMACOKINETIC STUDY IN CHILDREN IDENTIFIES TWO NOVEL BIOMARKERS OF DRUG CLEARANCE. Inflammatory bowel diseases. p. S100. [Online]. 
  
Back to record